6.
Quinn T
. Global burden of the HIV pandemic. Lancet. 1996; 348(9020):99-106.
DOI: 10.1016/s0140-6736(96)01029-x.
View
7.
Hall H, Espinoza L, Benbow N, Hu Y
. Epidemiology of HIV infection in large urban areas in the United States. PLoS One. 2010; 5(9):e12756.
PMC: 2939853.
DOI: 10.1371/journal.pone.0012756.
View
8.
Tobian A, H Gray R, Quinn T
. Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med. 2010; 164(1):78-84.
PMC: 2907642.
DOI: 10.1001/archpediatrics.2009.232.
View
9.
Ray M, Logan R, Sterne J, Hernandez-Diaz S, Robins J, Sabin C
. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2009; 24(1):123-37.
PMC: 2920287.
DOI: 10.1097/QAD.0b013e3283324283.
View
10.
Reynolds S, Makumbi F, Nakigozi G, Kagaayi J, H Gray R, Wawer M
. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS. 2010; 25(4):473-7.
PMC: 3261071.
DOI: 10.1097/QAD.0b013e3283437c2b.
View
11.
Attia S, Egger M, Muller M, Zwahlen M, Low N
. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009; 23(11):1397-404.
DOI: 10.1097/QAD.0b013e32832b7dca.
View
12.
Quinn T, Mann J, Curran J, Piot P
. AIDS in Africa: an epidemiologic paradigm. Science. 1986; 234(4779):955-63.
DOI: 10.1126/science.3022379.
View
13.
Brun-Vezinet F, Rouzioux C, Montagnier L, Chamaret S, Gruest J, Barre-Sinoussi F
. Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science. 1984; 226(4673):453-6.
DOI: 10.1126/science.6238406.
View
14.
Das M, Chu P, Santos G, Scheer S, Vittinghoff E, McFarland W
. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010; 5(6):e11068.
PMC: 2883572.
DOI: 10.1371/journal.pone.0011068.
View
15.
. HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011; 60(21):689-93.
View
16.
H Gray R, Serwadda D, Tobian A, Chen M, Makumbi F, Suntoke T
. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials. PLoS Med. 2009; 6(11):e1000187.
PMC: 2771764.
DOI: 10.1371/journal.pmed.1000187.
View
17.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L
. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99.
PMC: 3079639.
DOI: 10.1056/NEJMoa1011205.
View
18.
Montaner J, Lima V, Barrios R, Yip B, Wood E, Kerr T
. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010; 376(9740):532-9.
PMC: 2996043.
DOI: 10.1016/S0140-6736(10)60936-1.
View
19.
Serwadda D, Mugerwa R, Sewankambo N, Lwegaba A, Carswell J, Kirya G
. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985; 2(8460):849-52.
DOI: 10.1016/S0140-6736(85)90122-9.
View
20.
H Gray R, Serwadda D, Kong X, Makumbi F, Kigozi G, Gravitt P
. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis. 2010; 201(10):1455-62.
PMC: 2882881.
DOI: 10.1086/652184.
View